Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Pediatric Drugs and Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Diphtheria
      • 1.3.3 Influenza
      • 1.3.4 Hepatitis
      • 1.3.5 Pneumococcal Diseases
      • 1.3.6 Meningococcal Diseases
      • 1.3.7 Mumps
      • 1.3.8 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Pediatric Drugs and Vaccines Market Share by Application (2019-2025)
      • 1.4.2 Newborn
      • 1.4.3 Infant
      • 1.4.4 Child
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Pediatric Drugs and Vaccines Market Size
      • 2.1.1 Global Pediatric Drugs and Vaccines Revenue 2014-2025
      • 2.1.2 Global Pediatric Drugs and Vaccines Sales 2014-2025
    • 2.2 Pediatric Drugs and Vaccines Growth Rate by Regions
      • 2.2.1 Global Pediatric Drugs and Vaccines Sales by Regions 2014-2019
      • 2.2.2 Global Pediatric Drugs and Vaccines Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Pediatric Drugs and Vaccines Sales by Manufacturers
      • 3.1.1 Pediatric Drugs and Vaccines Sales by Manufacturers 2014-2019
      • 3.1.2 Pediatric Drugs and Vaccines Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Pediatric Drugs and Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.3 Pediatric Drugs and Vaccines Price by Manufacturers
    • 3.4 Key Manufacturers Pediatric Drugs and Vaccines Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Pediatric Drugs and Vaccines Market
    • 3.6 Key Manufacturers Pediatric Drugs and Vaccines Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Diphtheria Sales and Revenue (2014-2019)
      • 4.1.2 Influenza Sales and Revenue (2014-2019)
      • 4.1.3 Hepatitis Sales and Revenue (2014-2019)
      • 4.1.4 Pneumococcal Diseases Sales and Revenue (2014-2019)
      • 4.1.5 Meningococcal Diseases Sales and Revenue (2014-2019)
      • 4.1.6 Mumps Sales and Revenue (2014-2019)
      • 4.1.7 Others Sales and Revenue (2014-2019)
    • 4.2 Global Pediatric Drugs and Vaccines Sales Market Share by Type
    • 4.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type
    • 4.4 Pediatric Drugs and Vaccines Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Pediatric Drugs and Vaccines Sales by Application

    6 United States

    • 6.1 United States Pediatric Drugs and Vaccines Breakdown Data by Company
    • 6.2 United States Pediatric Drugs and Vaccines Breakdown Data by Type
    • 6.3 United States Pediatric Drugs and Vaccines Breakdown Data by Application

    7 European Union

    • 7.1 European Union Pediatric Drugs and Vaccines Breakdown Data by Company
    • 7.2 European Union Pediatric Drugs and Vaccines Breakdown Data by Type
    • 7.3 European Union Pediatric Drugs and Vaccines Breakdown Data by Application

    8 China

    • 8.1 China Pediatric Drugs and Vaccines Breakdown Data by Company
    • 8.2 China Pediatric Drugs and Vaccines Breakdown Data by Type
    • 8.3 China Pediatric Drugs and Vaccines Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Company
    • 9.2 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Type
    • 9.3 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Application
    • 9.4 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Countries
      • 9.4.1 Rest of World Pediatric Drugs and Vaccines Sales by Countries
      • 9.4.2 Rest of World Pediatric Drugs and Vaccines Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck & Co., Inc. (USA)
      • 10.1.1 Merck & Co., Inc. (USA) Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.1.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.1.5 Merck & Co., Inc. (USA) Recent Development
    • 10.2 Abbott Laboratories (USA)
      • 10.2.1 Abbott Laboratories (USA) Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.2.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.2.5 Abbott Laboratories (USA) Recent Development
    • 10.3 Amgen, Inc. (USA)
      • 10.3.1 Amgen, Inc. (USA) Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.3.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.3.5 Amgen, Inc. (USA) Recent Development
    • 10.4 Eli Lilly and Company (USA)
      • 10.4.1 Eli Lilly and Company (USA) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.4.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.4.5 Eli Lilly and Company (USA) Recent Development
    • 10.5 F. Hoffmann-La Roche Ltd (Switzerland)
      • 10.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.5.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
    • 10.6 Genentech, Inc. (USA)
      • 10.6.1 Genentech, Inc. (USA) Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.6.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.6.5 Genentech, Inc. (USA) Recent Development
    • 10.7 GlaxoSmithKline plc. (UK)
      • 10.7.1 GlaxoSmithKline plc. (UK) Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.7.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.7.5 GlaxoSmithKline plc. (UK) Recent Development
    • 10.8 Janssen Biologics B.V. (USA)
      • 10.8.1 Janssen Biologics B.V. (USA) Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.8.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.8.5 Janssen Biologics B.V. (USA) Recent Development
    • 10.9 Actelion Pharmaceuticals
      • 10.9.1 Actelion Pharmaceuticals Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.9.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.9.5 Actelion Pharmaceuticals Recent Development
    • 10.10 AstraZeneca Plc. (UK)
      • 10.10.1 AstraZeneca Plc. (UK) Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
      • 10.10.4 Pediatric Drugs and Vaccines Product Introduction
      • 10.10.5 AstraZeneca Plc. (UK) Recent Development
    • 10.11 Boehringer Ingelheim GmbH (Germany)
    • 10.12 Bristol-Myers Squibb Company (USA)
    • 10.13 Allergan, Inc. (USA)
    • 10.14 Novartis AG (Switzerland)
    • 10.15 Novo Nordisk A/S (Denmark)
    • 10.16 Pfizer, Inc. (USA)
    • 10.17 Sanofi S.A (France)
    • 10.18 Shionogi Inc. (USA)
    • 10.19 Shire Pharmaceuticals Group Plc. (UK)

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Pediatric Drugs and Vaccines Sales Channels
      • 11.2.2 Pediatric Drugs and Vaccines Distributors
    • 11.3 Pediatric Drugs and Vaccines Customers

    12 Market Forecast

    • 12.1 Global Pediatric Drugs and Vaccines Sales and Revenue Forecast 2019-2025
    • 12.2 Global Pediatric Drugs and Vaccines Sales Forecast by Type
    • 12.3 Global Pediatric Drugs and Vaccines Sales Forecast by Application
    • 12.4 Pediatric Drugs and Vaccines Forecast by Regions
      • 12.4.1 Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
      In 2019, the market size of Pediatric Drugs and Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pediatric Drugs and Vaccines.

      This report studies the global market size of Pediatric Drugs and Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Pediatric Drugs and Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Merck & Co., Inc. (USA)
      Abbott Laboratories (USA)
      Amgen, Inc. (USA)
      Eli Lilly and Company (USA)
      F. Hoffmann-La Roche Ltd (Switzerland)
      Genentech, Inc. (USA)
      GlaxoSmithKline plc. (UK)
      Janssen Biologics B.V. (USA)
      Actelion Pharmaceuticals
      AstraZeneca Plc. (UK)
      Boehringer Ingelheim GmbH (Germany)
      Bristol-Myers Squibb Company (USA)
      Allergan, Inc. (USA)
      Novartis AG (Switzerland)
      Novo Nordisk A/S (Denmark)
      Pfizer, Inc. (USA)
      Sanofi S.A (France)
      Shionogi Inc. (USA)
      Shire Pharmaceuticals Group Plc. (UK)

      Market Segment by Product Type
      Diphtheria
      Influenza
      Hepatitis
      Pneumococcal Diseases
      Meningococcal Diseases
      Mumps
      Others

      Market Segment by Application
      Newborn
      Infant
      Child

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Pediatric Drugs and Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Pediatric Drugs and Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Pediatric Drugs and Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now